1-180272020-G-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_033343.4(LHX4):​c.778+14G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0862 in 1,608,636 control chromosomes in the GnomAD database, including 7,685 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.091 ( 841 hom., cov: 31)
Exomes 𝑓: 0.086 ( 6844 hom. )

Consequence

LHX4
NM_033343.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.384

Publications

5 publications found
Variant links:
Genes affected
LHX4 (HGNC:21734): (LIM homeobox 4) This gene encodes a member of a large protein family which contains the LIM domain, a unique cysteine-rich zinc-binding domain. The encoded protein is a transcription factor involved in the control of differentiation and development of the pituitary gland. Mutations in this gene cause combined pituitary hormone deficiency 4. [provided by RefSeq, Dec 2010]
ACBD6 (HGNC:23339): (acyl-CoA binding domain containing 6) Predicted to enable fatty-acyl-CoA binding activity and lipid binding activity. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
LHX4-AS1 (HGNC:40982): (LHX4 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 1-180272020-G-T is Benign according to our data. Variant chr1-180272020-G-T is described in ClinVar as Benign. ClinVar VariationId is 262224.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033343.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LHX4
NM_033343.4
MANE Select
c.778+14G>T
intron
N/ANP_203129.1
LHX4-AS1
NR_037642.1
n.349-49C>A
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LHX4
ENST00000263726.4
TSL:1 MANE Select
c.778+14G>T
intron
N/AENSP00000263726.2
ACBD6
ENST00000642319.1
c.*1254-49C>A
intron
N/AENSP00000495710.1
ACBD6
ENST00000415414.5
TSL:2
n.349-49C>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0911
AC:
13800
AN:
151562
Hom.:
832
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0950
Gnomad AMI
AF:
0.0407
Gnomad AMR
AF:
0.186
Gnomad ASJ
AF:
0.0144
Gnomad EAS
AF:
0.0440
Gnomad SAS
AF:
0.0549
Gnomad FIN
AF:
0.0690
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0823
Gnomad OTH
AF:
0.0718
GnomAD2 exomes
AF:
0.104
AC:
25553
AN:
246848
AF XY:
0.0936
show subpopulations
Gnomad AFR exome
AF:
0.0992
Gnomad AMR exome
AF:
0.311
Gnomad ASJ exome
AF:
0.0130
Gnomad EAS exome
AF:
0.0368
Gnomad FIN exome
AF:
0.0660
Gnomad NFE exome
AF:
0.0794
Gnomad OTH exome
AF:
0.0881
GnomAD4 exome
AF:
0.0857
AC:
124789
AN:
1456954
Hom.:
6844
Cov.:
32
AF XY:
0.0837
AC XY:
60619
AN XY:
724512
show subpopulations
African (AFR)
AF:
0.0942
AC:
3140
AN:
33348
American (AMR)
AF:
0.298
AC:
13210
AN:
44344
Ashkenazi Jewish (ASJ)
AF:
0.0134
AC:
346
AN:
25844
East Asian (EAS)
AF:
0.0522
AC:
2070
AN:
39664
South Asian (SAS)
AF:
0.0594
AC:
5098
AN:
85872
European-Finnish (FIN)
AF:
0.0673
AC:
3559
AN:
52856
Middle Eastern (MID)
AF:
0.0342
AC:
171
AN:
4994
European-Non Finnish (NFE)
AF:
0.0835
AC:
92698
AN:
1109902
Other (OTH)
AF:
0.0748
AC:
4497
AN:
60130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
5482
10963
16445
21926
27408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3534
7068
10602
14136
17670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0912
AC:
13827
AN:
151682
Hom.:
841
Cov.:
31
AF XY:
0.0923
AC XY:
6834
AN XY:
74066
show subpopulations
African (AFR)
AF:
0.0950
AC:
3933
AN:
41384
American (AMR)
AF:
0.187
AC:
2852
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.0144
AC:
50
AN:
3472
East Asian (EAS)
AF:
0.0434
AC:
221
AN:
5098
South Asian (SAS)
AF:
0.0553
AC:
260
AN:
4698
European-Finnish (FIN)
AF:
0.0690
AC:
727
AN:
10534
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0823
AC:
5590
AN:
67934
Other (OTH)
AF:
0.0711
AC:
150
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
590
1180
1770
2360
2950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0778
Hom.:
723
Bravo
AF:
0.103
Asia WGS
AF:
0.0500
AC:
174
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Short stature-pituitary and cerebellar defects-small sella turcica syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
14
DANN
Benign
0.83
PhyloP100
0.38
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3806302; hg19: chr1-180241155; API